Status:
COMPLETED
Lornoxicam With Low Dose Ketamine Versus Pethidine to Control Pain of Acute Renal Colic
Lead Sponsor:
Ain Shams University
Conditions:
Renal Colic
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Patients with acute renal colic divided into 2 groups. Group L administered ornoxicam and Group P administered pethidine and VAS was recorded for both groups.
Detailed Description
Prospective, randomized, double blind clinical study including 120 patients with acute renal pain admitted in emergency department. They were randomly assigned to one of two groups using a computer-ge...
Eligibility Criteria
Inclusion
- Patients, who did not administer any analgesics at least within the last two hours. - -
- Patients aged between 20-60 years.
Exclusion
- Patients with previous renal surgery
- liver and renal failure
- hypersensitivity to lornoxicam, ketamine and pethidine, history of peptic ulcer,
- gastrointestinal bleeding and perforation,
- hypertensive and history of cardiac diseases
- pregnancy and lactation and
- urine examination showing more than 5 leukocytes suggestive of pyuria.
- patients with hyperthyroidism are excluded
Key Trial Info
Start Date :
January 2 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03780556
Start Date
January 2 2016
End Date
May 1 2018
Last Update
December 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ِAin Shams University hospitals
Cairo, Egypt